Dr. Anand Chintakrindi




  • Dr.  Anand Chintakrindi

    Designation:  Assistant Professor

  • Educational Qualifications
    Ph.D. (Tech.) (Pharmaceutical Chemistry)
    M. Pharm (Pharmaceutical Chemistry)
    B. Pharm


    Academic Affiliations
    •  Currently working as Assistant Professor in Pharmaceutical Chemistry

    •  Worked as 

    • Assistant Professor (Ad-hoc) in Pharmacy at Bombay College of Pharmacy
    • Senior Officer in Intellectual Property Management at Macleods Pharmaceuticals Ltd
    • Assistant Professor in Pharmaceutical Chemistry at Yadavrao Tasgaonkar Institute of Pharmacy
    • Lecturer in Pharmacy at Prin. K. M. Kundnani College of Pharmacy
    • Research Associate in Analytical R & D at Rubicon Research Private Limited


    Professional Affiliations
    Pharmacy Council of India
  • Teaching
    •   Organic Chemistry
    •   Medicinal Chemistry
    •   Advanced Organic Chemistry
    •   Advanced Medicinal Chemistry
    •   Computer Aided Drug Design
    •   Biochemistry

  • Research
    Area Of Research
    •  Computer Aided Drug Design
    •  Synthesis and Characterisation
    •  Anti-viral agents
    •  Anti-protozoal agents
    •  Antigen-Antibody complexes




  • Publications

    1. Anand S. Chintakrindi, Devanshi J. Gohil, Abhay S. Chowdhary, Meena A. Kanyalkar Design, Synthesis and Biological Evaluation of Substituted Flavones and Aurones as Potential Anti-Influenza Agents. Bioorg. Med. Chem. 1, 2020, 115191 (Impact factor: 2.802) DOI: 10.1016/j.bmc.2019.115191

    2. Khushboo D. Malbari, Anand S. Chintakrindi, Lata R. Ganji, Devanshi J. Gohil, Sweta T. Kothari, Mamata V. Joshi, Meena A. Kanyalkar. Structure-Aided Drug Development of Potential Neuraminidase Inhibitors Against Pandemic H1N1 Exploring Alternate Binding Mechanism. Mol. Divers. 23, 2019, 927-951 (Impact Factor: 2.229) DOI: 10.1007/s11030-019-09919-6

    3. Khushboo Malbari, Hephzibah Gonsalves, Anand Chintakrindi, Devanshi Gohil, Mamata Joshi, Sweta Kothari, Sudha Srivastava, Abhay Chowdhary, Meena Kanyalkar. In search of effective H1N1 neuraminidase inhibitor by molecular docking, antiviral evaluation and membrane interaction studies using NMR. Acta Virologica, 62, 2018, 179-190. DOI: 10.4149/av_2018_209

    4. Anand S. Chintakrindi, Devanshi J. Gohil, Sweta T. Kothari, Abhay S. Chowdhary, Meena A. Kanyalkar. Design, Synthesis and Evaluation of Chalcones as H1N1 Neuraminidase inhibitors. Med. Chem. Res. 27 (4), 2018, 1013-1025. (Impact Factor: 1.607) DOI: 10.1007/s00044-017-2124-2

    5. Pradip Suruse, Khushboo Malbari, Anand Chintakrindi, Devanshi Gohil, Mamata Joshi, Sudha Srivastava, Sweta Kothari, Abhay Chowdhary, Meena Kanyalkar. Virucidal activity of newly synthesized chalcone derivatives against H1N1 virus supported by molecular docking and membrane interaction studies. J. Antivir. Antiretrovir., 8, 2016, 079-089. (Impact Factor: 1.830) DOI: 10.4172/jaa.1000139

    6. Anand S. Chintakrindi, Elvis A. F. Martis, Devanshi J. Gohil, Sweta T. Kothari, Abhay S. Chowdhary, Evans C. Coutinho, Meena A Kanyalkar. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1. Curr. Comput. Aided Drug Des., 12, 2016, 272-281. (Impact Factor: 1.297) DOI: 10.2174/1573409912666160713111242

    7. Devanshi Gohil, Sweta Kothari, Pramod Shinde, Anand Chintakrindi, Rhuta Meharunkar, Rajas Warke, Meena Kanyalkar, Abhay Chowdhary, Ranjana Deshmukh. Oseltamivir Resistant Influenza A (H1N1) Virus Infection in Mumbai, India. J. Antivir. Antiretrovir., 7, 2015, 108-114. (Impact Factor: 1.830) DOI: 10.4172/jaa.1000126

    8. Devanshi Gohil, Sweta Kothari, Pramod Shinde, Anand Chintakrindi, Rhuta Meharunkar, Rajas Warke, Meena Kanyalkar, Abhay Chowdhary, Ranjana Deshmukh. Genetic characterization of oseltamivir-resistant seasonal influenza A (H1N1) virus circulating during 2009 pandemic influenza in Mumbai. Int. J. Adv. Res., 3, 2015, 252 – 261.

    9. Devanshi Gohil, Sweta Kothari, Pramod Shinde, Anand Chintakrindi, Rhuta Meharunkar, Rajas Warke, Meena Kanyalkar, Abhay Chowdhary, Ranjana Deshmukh. Drug susceptibility of influenza A/H3N2 strains co-circulating during 2009 influenza pandemic: First report from Mumbai. Infection, Genetics and Evolution, 29, 2015, 75 – 81. (Impact Factor: 3.015) DOI: 10.1016/j.meegid.2014.11.005

    10. Anand Chintakrindi, Charlotte D'souza and Meena Kanyalkar, Rational Development of Neuraminidase Inhibitor as Novel Anti-Flu Drug. Mini Rev. Med. Chem., 12, 2012, 1273 – 1381. (Impact Factor: 2.903) DOI: 10.2174/138955712802761997

    11. Anand S. Chintakrindi, Mushtaque S. Shaikh and Evans C. Coutinho, De novo design of 7-aminocoumarin derivatives as novel falcipain-3 inhibitors. J. Mol. Model., 18, 2012, 1481-1493. (Impact Factor: 1.736) DOI: 10.1007/s00894-011-1177-2

  • Title of Grants Fetched: Academic Year Funding Agency Amount Sanctioned
    MD simulations of the antigen-antibody complexes 2019-20 University of California San Francisco Fee Waiver worth US $ 500 for Academic License of AMBER 18
    Research Strategies for design of novel therapies of COVID-19 2019-20 Dassault Systems India Pvt. Ltd. Six-month license for BIOVIA Discovery Studio Academic Research Suite
    Title of Industrial Projects: Academic Year Industry Amount Sanctioned
    NIL
    NIL
  • •  Junior and Senior Research Fellowship awarded by Indian Council of Medical Research, New Delhi, 2010 - 2013.
    •   Scholarship awarded by All India Council for Technical Education, New Delhi, 2007-2009 for securing AIR 319 in GATE 2007.
    •  Scholarships awarded by Ratan Tata Trust and the J.R.D. Tata trust, for obtaining distinctions and first class respectively during the course of study in pharmacy.